EP1276751A4 - Nouveaux acides nucleiques et polypeptides - Google Patents

Nouveaux acides nucleiques et polypeptides

Info

Publication number
EP1276751A4
EP1276751A4 EP01912764A EP01912764A EP1276751A4 EP 1276751 A4 EP1276751 A4 EP 1276751A4 EP 01912764 A EP01912764 A EP 01912764A EP 01912764 A EP01912764 A EP 01912764A EP 1276751 A4 EP1276751 A4 EP 1276751A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01912764A
Other languages
German (de)
English (en)
Other versions
EP1276751A2 (fr
Inventor
Y Tom Tang
Chenghua Liu
Ping Zhou
Vinod Asundi
Jie Zhang
Qing A Zhao
Feiyan Ren
Aidong J Xue
Yonghong Yang
Tom Wehrman
Jian-Rui Wang
Yunqing Ma
Dunrui Wang
Rui-Hong Chen
Chongjun Xu
Radoje Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1276751A2 publication Critical patent/EP1276751A2/fr
Publication of EP1276751A4 publication Critical patent/EP1276751A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP01912764A 2000-02-28 2001-02-26 Nouveaux acides nucleiques et polypeptides Withdrawn EP1276751A4 (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US515126 1983-07-19
US664641 1984-10-25
US51512600A 2000-02-28 2000-02-28
US57740900A 2000-05-18 2000-05-18
US577409 2000-05-18
US59770700A 2000-06-17 2000-06-17
US597707 2000-06-17
US61680700A 2000-07-14 2000-07-14
US616807 2000-07-14
US66464100A 2000-09-19 2000-09-19
PCT/US2001/004926 WO2001064834A2 (fr) 2000-02-28 2001-02-26 Nouveaux acides nucleiques et polypeptides

Publications (2)

Publication Number Publication Date
EP1276751A2 EP1276751A2 (fr) 2003-01-22
EP1276751A4 true EP1276751A4 (fr) 2005-04-06

Family

ID=27541818

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01912764A Withdrawn EP1276751A4 (fr) 2000-02-28 2001-02-26 Nouveaux acides nucleiques et polypeptides

Country Status (4)

Country Link
EP (1) EP1276751A4 (fr)
AU (1) AU2001241511A1 (fr)
CA (1) CA2401505A1 (fr)
WO (1) WO2001064834A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
EP1196562A4 (fr) * 1999-06-29 2007-01-10 Autogen Res Pty Ltd Nouveaux genes et leur utilisation pour moduler l'obesite, le diabete et les desequilibres energetiques
ES2269353T3 (es) * 2000-02-29 2007-04-01 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nueva proteina ulip/crmp humana y su utilizacion en el diagnostico y la terapia de canceres y de sindromes neurologicos paraneoplasicos.
US7235649B2 (en) 2000-03-24 2007-06-26 Duke University Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
CA2429196A1 (fr) 2000-03-24 2001-10-04 Duke University Caracterisation d'interactions ligands-grp94 et methodes de purification, de criblage et de traitement associees
WO2001090321A2 (fr) * 2000-05-19 2001-11-29 Millennium Pharmaceuticals, Inc. 55158, une nouvelle anhydrase carbonique humaine et son utilisation
WO2003008446A1 (fr) * 2001-07-19 2003-01-30 Mitsubishi Pharma Corporation Polypeptides se rapportant au transfert de signaux de recepteur de produits terminaux a glycation avancee
WO2003027279A1 (fr) * 2001-09-25 2003-04-03 Sony Corporation Inhibiteur de l'histone acetylase de p300
WO2003044171A2 (fr) * 2001-11-16 2003-05-30 Incyte Genomics, Inc. Proteines associees a des organites
AU2002365517A1 (en) * 2001-11-26 2003-06-10 Hybrigenics Protein-protein interactions involving transforming growth factor beta signalling
AU2003219085A1 (en) * 2002-03-20 2003-09-29 Novartis Ag Methods for diagnosing and treating schizophrenia
GB0217033D0 (en) * 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
AU2003252693A1 (en) 2002-07-25 2004-04-23 Sony Corporation Factor participating in transcriptional regulation
WO2004016733A2 (fr) 2002-08-16 2004-02-26 Agensys, Inc. Acides nucleiques et proteines correspondantes connues sous 251p5g2 que l'on utilise dans le traitement et la detection de cancers
WO2004090113A2 (fr) * 2003-03-31 2004-10-21 Seattle Genetics, Inc. L53, antigene associe au cancer du poumon et ses utilisations
EP2070546A1 (fr) * 2004-04-09 2009-06-17 Takeda Pharmaceutical Company Limited Agents préventifs/remèdes pour le cancer
WO2007015704A2 (fr) * 2004-10-29 2007-02-08 University Of Rochester Vecteurs de bacteriophage modifie et utilisation de ceux-ci
NZ591825A (en) * 2005-07-26 2012-10-26 Cms Peptides Patent Holding Company Ltd Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating fatigue
CN105228640B (zh) * 2013-02-26 2018-01-16 王荣福 Phf20和jmjd3组合物及其在肿瘤免疫治疗中的使用方法
EP3609577A4 (fr) 2017-04-14 2021-03-24 University of Massachusetts Adipokines sélectives vis-à-vis de la graisse brune

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831052A (en) * 1997-05-07 1998-11-03 Incyte Pharmaceuticals, Inc. New human translocation associated protein
WO2001049728A2 (fr) * 2000-01-06 2001-07-12 Protegene Inc. Proteines humaines a domaines hydrophobes et adn codant ces proteines
EP1130094A2 (fr) * 1999-07-08 2001-09-05 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831052A (en) * 1997-05-07 1998-11-03 Incyte Pharmaceuticals, Inc. New human translocation associated protein
EP1130094A2 (fr) * 1999-07-08 2001-09-05 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001049728A2 (fr) * 2000-01-06 2001-07-12 Protegene Inc. Proteines humaines a domaines hydrophobes et adn codant ces proteines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EMBL; 17 March 1999 (1999-03-17), XP002303786, retrieved from EBI accession no. EMBL:AI472339 Database accession no. AI472339 *

Also Published As

Publication number Publication date
AU2001241511A1 (en) 2001-09-12
CA2401505A1 (fr) 2001-09-07
WO2001064834A2 (fr) 2001-09-07
EP1276751A2 (fr) 2003-01-22
WO2001064834A8 (fr) 2002-02-14

Similar Documents

Publication Publication Date Title
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1341804A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1504099A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1381621A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1432800A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1470238A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1242443A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
IL206414A0 (en) Novel receptor nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
EP1430112A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1368475A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
WO2002016439A8 (fr) Nouveaux acides nucleiques et polypeptides
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001263005A8 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020926

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20050217

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060314